Pharma

Your Article Summary

See Latest Articles

Medtronic Announces FDA Approval and Market Availability of Sprint Quattro Secure S Single Coil Defibrillation Lead
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/04/08

Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval of the Medtronic Sprint Quattro Secure S single coil defibrillation lead (Model 6935) for use with implantable defibrillators in patients at risk for dangerous tachyarrhythmias (fast heartbeats) and sudden cardiac arrest. This new defibrillation lead is an addition to the Sprint Quattro family that is supported by more than seven years of post-market performance data. It provides an option for physicians who prefer a specific type of lead for patients with unique anatomies and is designed to help reduce tip pressure. The U.S. approval and market release of this single coil option follows its recent European approval and launch.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals